The Sitagliptin Saga: More Evidence for Possible HF Hazard The Sitagliptin Saga: More Evidence for Possible HF Hazard

Initiating the drug in patients with diabetes who already have HF may elevate the risk of subsequent HF hospitalization, suggests a retrospective analysis from a national US cohort. Heartwire
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Source Type: news